US
The Expert Panel will review and revise USP General Chapter <665> and informational chapter <1665> to modernize standards for plastic components and single-use systems in pharmaceutical manufacturing. The work focuses on aligning with ICH Q3E, clarifying scope, risk‑based frameworks, and distinguishing extractables from leachables.
USP is dedicated to helping improve global health through standards setting in compounding, biologics, pharmaceutical manufacturing and other fields.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for US.
US didn’t post a salary, so this is our estimate from similar listings.
17% above the average for this role
Principal Scientist – Extractables & Leachables (E&L) (x|f|m)
Sartorius
Specialist– MS&T
Novartis
Expert Toxicologist for Impurity Safety Assessment and Risk Management
Roche
Principal Scientist
Fresenius Kabi
Extractables y Lixiviables Team Leader
ChemoMetec
Senior Research Associate-AD
Piramal Pharma Solutions